Clinical Trial Update: Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating mechanisms of weight loss maintenance with SGLT2 inhibitors has been withdrawn. The study was sponsored by the University o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Obesity, Weight Loss | Phase 2 | Status: WITHDRAWN